333 Empowering cancer immunotherapy by mesothelin-directed CAR T cells engineered to secret checkpoint inhibitors

• Jiantao Wang,
• Huajing Wang,
• Xian-Yang Li,
• Xiaowen He,
• Xinran Luo,
• Zhenwei Zhong

Affiliations

Jiantao Wang

Ophthalmology, Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Shenzhen University School of Medicine, Shenzhen, Guangdong, China

Huajing Wang

Oricell Therapeutics, Shanghai, China

Xian-Yang Li

Oricell Therapeutics, Shanghai, China

Xiaowen He

Oricell Therapeutics, Shanghai, China

Xinran Luo

Oricell Therapeutics, Shanghai, China

Zhenwei Zhong

Oricell Therapeutics, Shanghai, China